DarioHealth Corp. (NASDAQ:DRIO) stock dropped 14% post quarterly results, with mixed revenue and smaller losses. Analysts predict a 39% revenue increase in 2024 and a 22% reduction in losses. Despite revenue forecast cut, analysts expect accelerated growth.